A detailed history of Coho Partners, Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Coho Partners, Ltd. holds 692,063 shares of JNJ stock, worth $114 Million. This represents 3.56% of its overall portfolio holdings.

Number of Shares
692,063
Previous 908,032 23.78%
Holding current value
$114 Million
Previous $144 Million 29.58%
% of portfolio
3.56%
Previous 3.57%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$144.38 - $157.78 $31.2 Million - $34.1 Million
-215,969 Reduced 23.78%
692,063 $101 Million
Q1 2024

May 09, 2024

SELL
$155.22 - $162.74 $15.1 Million - $15.8 Million
-97,300 Reduced 9.68%
908,032 $144 Million
Q4 2023

Jan 09, 2024

SELL
$145.6 - $158.88 $30.4 Million - $33.2 Million
-208,785 Reduced 17.2%
1,005,332 $158 Million
Q3 2023

Oct 24, 2023

SELL
$155.75 - $174.48 $18.5 Million - $20.7 Million
-118,533 Reduced 8.89%
1,214,117 $189 Million
Q2 2023

Jul 24, 2023

SELL
$154.35 - $166.11 $9.58 Million - $10.3 Million
-62,097 Reduced 4.45%
1,332,650 $221 Million
Q1 2023

Apr 25, 2023

SELL
$151.05 - $180.26 $2.54 Million - $3.03 Million
-16,804 Reduced 1.19%
1,394,747 $216 Million
Q4 2022

Jan 11, 2023

BUY
$160.2 - $179.79 $143,859 - $161,451
898 Added 0.06%
1,411,551 $249 Million
Q3 2022

Oct 07, 2022

BUY
$161.33 - $179.52 $8.91 Million - $9.91 Million
55,215 Added 4.07%
1,410,653 $230 Million
Q2 2022

Jul 21, 2022

SELL
$168.19 - $186.01 $11.1 Million - $12.3 Million
-66,264 Reduced 4.66%
1,355,438 $241 Million
Q1 2022

Apr 27, 2022

SELL
$158.14 - $179.59 $6.13 Million - $6.96 Million
-38,733 Reduced 2.65%
1,421,702 $252 Million
Q4 2021

Jan 14, 2022

SELL
$155.93 - $173.01 $16.3 Million - $18.1 Million
-104,413 Reduced 6.67%
1,460,435 $250 Million
Q3 2021

Oct 20, 2021

SELL
$161.5 - $179.47 $5.01 Million - $5.56 Million
-30,994 Reduced 1.94%
1,564,848 $253 Million
Q2 2021

Jul 20, 2021

BUY
$159.48 - $171.07 $1.86 Million - $1.99 Million
11,644 Added 0.74%
1,595,842 $263 Million
Q1 2021

Apr 20, 2021

SELL
$153.07 - $170.48 $920,409 - $1.03 Million
-6,013 Reduced 0.38%
1,584,198 $260 Million
Q4 2020

Jan 27, 2021

BUY
$137.11 - $157.38 $13.3 Million - $15.2 Million
96,776 Added 6.48%
1,590,211 $250 Million
Q3 2020

Nov 02, 2020

BUY
$140.38 - $153.83 $22.3 Million - $24.4 Million
158,849 Added 11.9%
1,493,435 $222 Million
Q2 2020

Jul 28, 2020

BUY
$128.81 - $155.51 $3.93 Million - $4.74 Million
30,473 Added 2.34%
1,334,586 $188 Million
Q1 2020

Apr 27, 2020

SELL
$111.14 - $153.99 $4.43 Million - $6.14 Million
-39,877 Reduced 2.97%
1,304,113 $171 Million
Q4 2019

Jan 29, 2020

BUY
$127.5 - $146.44 $4.94 Million - $5.68 Million
38,756 Added 2.97%
1,343,990 $196 Million
Q3 2019

Oct 29, 2019

SELL
$126.95 - $142.14 $5.57 Million - $6.24 Million
-43,899 Reduced 3.25%
1,305,234 $169 Million
Q2 2019

Aug 08, 2019

SELL
$131.15 - $144.24 $4.77 Million - $5.25 Million
-36,365 Reduced 2.62%
1,349,133 $188 Million
Q1 2019

Apr 26, 2019

BUY
$125.72 - $139.79 $5.23 Million - $5.81 Million
41,563 Added 3.09%
1,385,498 $194 Million
Q4 2018

Feb 04, 2019

BUY
$122.84 - $147.84 $5.66 Million - $6.81 Million
46,053 Added 3.55%
1,343,935 $173 Million
Q3 2018

Oct 29, 2018

SELL
$121.58 - $142.88 $4.11 Million - $4.83 Million
-33,771 Reduced 2.54%
1,297,882 $179 Million
Q2 2018

Aug 03, 2018

BUY
$119.4 - $131.76 $44.8 Million - $49.5 Million
375,609 Added 39.29%
1,331,653 $162 Million
Q1 2018

May 09, 2018

BUY
$125.1 - $148.14 $41.4 Million - $49 Million
331,063 Added 52.97%
956,044 $123 Million
Q4 2017

Jan 30, 2018

SELL
$131.22 - $143.62 $2.93 Million - $3.21 Million
-22,357 Reduced 3.45%
624,981 $87.3 Million
Q3 2017

Nov 14, 2017

SELL
$129.47 - $135.38 $5.81 Million - $6.08 Million
-44,905 Reduced 6.49%
647,338 $84.2 Million
Q2 2017

Aug 07, 2017

BUY
N/A
692,243
692,243 $0

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $430B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Coho Partners, Ltd. Portfolio

Follow Coho Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coho Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Coho Partners, Ltd. with notifications on news.